Top Markets
Coin of the day
TetraLogic Pharmaceuticals Corporation TetraLogic Pharmaceuticals Corporation

TetraLogic Pharmaceuticals Corporation

TLOG
Rank in Stocks #42528
TetraLogic Pharmaceuticals Corporation operates as a clinical-stage... TetraLogic Pharmaceuticals Corporation operates as a clinical-stage biopharmaceutical firm, concentrating its efforts on identifying and advancing small-molecule treatments for cancer and infectious diseases. The company's development pipeline features two key clinical-stage drug candidates: birinapant and SHAPE. Birinapant, a small molecule, functions as a Second Mitochondrial Activator of Caspases (SMAC) mimetic, promoting programmed cell death, or apoptosis, in compromised cells. SHAPE, another proprietary compound, is a histone deacetylase (HDAC) inhibitor intended for topical administration to address early-stage cutaneous T-cell lymphoma. Furthermore, TetraLogic Pharmaceuticals has a research collaboration with the Walter and Eliza Hall Institute of Medical Research to explore the application of SMAC-mimetics, including birinapant, in treating infectious diseases. Founded in 2001 as Gentara Corporation, the company adopted its current name, TetraLogic Pharmaceuticals Corporation, in January 2006 and maintains its headquarters in Malvern, Pennsylvania.
Share Price
$0.00004
Last synced: 2026-08-11
Market Cap
$979.00
Change (1 day)
0.00%
Change (1 year)
-96.00%
Country
US
Trade TetraLogic Pharmaceuticals Corporation (TLOG)

Category

Stock price history for TetraLogic Pharmaceuticals Corporation (TLOG)
Highest end of day price: $0.00 on 2026-08-01

Lowest end of day price: $7.80 on 2013-12-01
Stock price history of TetraLogic Pharmaceuticals Corporation from 2013 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) 0.00%
2025 17.69%
2024 -14.40%
2023 -62.44%
2022 -94.10%
2021 -63.46%
2020 -64.19%
2019 262.70%
2018 -72.55%
2017 -41.80%
2016 -96.37%
2015 -69.79%
2014 -34.13%
2013 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
$527.87 33.33%
US
$873.57 35.10%
NL
$736.38 7.69%
CH
$1.08K -6.44%
KR
$263.09 18.09%
BE